Aytu Biopharma, Inc.
AYTU
$1.27
$0.010.79%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 70.87% | 74.46% | 7.08% | 55.40% | 76.56% |
| Total Depreciation and Amortization | -16.53% | -15.27% | -14.95% | -14.02% | -14.61% |
| Total Amortization of Deferred Charges | -24.27% | 10.04% | 60.82% | -- | -- |
| Total Other Non-Cash Items | -127.00% | -94.36% | 52.13% | 23.31% | -74.86% |
| Change in Net Operating Assets | 1,166.92% | -374.02% | -14.47% | 71.40% | 98.80% |
| Cash from Operations | -88.99% | -162.16% | 72.94% | 140.60% | 121.99% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 106.76% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 80.68% | -7.66% | -181.20% | -1,316.22% | -- |
| Cash from Investing | 210.64% | 154.47% | -181.20% | -14,900.00% | -445.95% |
| Total Debt Issued | 527.24% | 467.50% | -- | -199.73% | -119.42% |
| Total Debt Repaid | -448.80% | -487.96% | -570.16% | -812.16% | 84.94% |
| Issuance of Common Stock | -17.29% | -32.80% | -77.74% | -79.64% | -78.98% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 6.60% | 82.64% | 34.86% | 74.54% | 41.52% |
| Cash from Financing | 95.58% | 132.12% | -114.23% | -158.78% | -146.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3,003.57% | 103.74% | -182.18% | 106.89% | 100.18% |
